Handheld device for counterfeit drug detection to be tested in Africa

BMJ 2013; 346 doi: (Published 26 April 2013) Cite this as: BMJ 2013;346:f2732
  1. Michael McCarthy
  1. 1Seattle

The United States’ Food and Drug Administration (FDA) will begin testing a handheld device to detect counterfeit and substandard malaria drugs in Africa this year, the agency has said.

The battery operated device, CD-3, detects counterfeit and substandard products by illuminating them with a variety of wavelengths of light, ranging from ultraviolet to infrared. When placed side by side under the light and viewed through the device’s camera system, the authentic and …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial